Cutler Bay, FLORIDA5 Active Studies

Ankylosing Spondylitis Clinical Trials in Cutler Bay, FLORIDA

Find 5 actively recruiting ankylosing spondylitis clinical trials in Cutler Bay, FLORIDA. Connect with local research sites and explore new treatment options.

5
Active Trials
5
Sponsors
1,304
Enrolling

Recruiting Ankylosing Spondylitis Studies in Cutler Bay

RecruitingCutler Bay, FLORIDANCT06932263

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolle...

540 participants
AstraZeneca
View Study Details
RecruitingCutler Bay, FLORIDANCT06609239

Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Moderatetosevere Asthma.

This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with moderate-to-severe asthma who have previously completed the parent ...

530 participants
Sanofi
View Study Details
RecruitingCutler Bay, FLORIDANCT06496607

A Study to Evaluate Solriktug in Adult Participants With Asthma

Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma....

124 participants
Uniquity One (UNI)
View Study Details
RecruitingCutler Bay, FLORIDANCT06344052

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

The goal of this clinical trial is to evaluate the efficacy of using SP-002 in participants with locally advanced Basal cell carcinoma. The main question it aims to answer is what the objective respon...

80 participants
Stamford Pharmaceuticals, Inc.
View Study Details
RecruitingCutler Bay, FLORIDANCT06822517

A Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease

This trial is a randomized, double-blind, placebo-controlled Phase 1b study evaluating the safety/tolerability, PK, and pharmacodynamics of VENT 02, administered orally at 1 dose level twice daily (BI...

30 participants
Ventus Therapeutics U.S., Inc.
View Study Details

About Ankylosing Spondylitis Clinical Trials in Cutler Bay

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 5 ankylosing spondylitis clinical trials recruiting participants in Cutler Bay, FLORIDA. These studies are seeking a combined 1,304 participants. Research is being sponsored by AstraZeneca, Sanofi, Uniquity One (UNI) and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Cutler Bay — FAQ

Are there ankylosing spondylitis clinical trials in Cutler Bay?

Yes, there are 5 ankylosing spondylitis clinical trials currently recruiting in Cutler Bay, FLORIDA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Cutler Bay?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Cutler Bay research site will contact you about next steps.

Are clinical trials in Cutler Bay free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Cutler Bay studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 5 active trials in Cutler Bay are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov